Better Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Better Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q3 2023.
  • Better Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $3K, unchanged year-over-year.
  • Better Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $7K.
  • Better Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$153K, a 200% decline from 2020.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $3K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q3 2022 $3K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2021 $1K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$151K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.